Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2353
Source ID: NCT03380325
Associated Drug: Iloprost Infusion
Title: The Effect of Iloprost on Capillary Recruitment and Insulin Sensitivity in Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus, Type 2|Insulin Sensitivity/Resistance
Interventions: DRUG: Iloprost infusion
Outcome Measures: Primary: Rate of disappearance, Glucose uptake in peripheral tissues during hyperinsulinemic euglycemic clamp, During the clamp|Capillary recruitment, Change in skeletal muscle en myocardial microvascular blood volume upon insulin infusion, Before and during the clamp | Secondary: Continous cardiovascular monitoring, Diastolic blood pressure, Before and during the clamp|Continous cardiovascular monitoring, Systolic blood pressure, Before and during the clamp|Continous cardiovascular monitoring, Cardiac output, Before and during the clamp|Continous cardiovascular monitoring, Heart rate, Before and during the clamp|Continous cardiovascular monitoring, Stroke volume, Before and during the clamp|Continous cardiovascular monitoring, Systemic vascular resistance, Before and during the clamp
Sponsor/Collaborators: Sponsor: Amsterdam UMC, location VUmc
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 15
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2016-05-11
Completion Date: 2017-06-29
Results First Posted:
Last Update Posted: 2019-07-18
Locations: VU University Medical Center, Amsterdam, Noord-Holland, 1081 HV, Netherlands
URL: https://clinicaltrials.gov/show/NCT03380325